Gaucher disease: Gene frequencies and genotype/phenotype correlations

Genetic Testing

Volumn 1, Issue 1, 1997, Pages 5-12

  Grabowski, Gregory A ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

ALLELE; ENZYMOLOGY; FEMALE; GAUCHER DISEASE; GENE FREQUENCY; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; JEW; MALE; METABOLISM; MUTATION; PHENOTYPE; REVIEW;

ALLELES; FEMALE; GAUCHER DISEASE; GENE FREQUENCY; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; GLUCOSYLCERAMIDASE; HETEROZYGOTE; HUMANS; JEWS; MALE; MUTATION; PHENOTYPE;

EID: 0031292176     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1997.1.5     Document Type: Article

References (42)

1. ABRAHAMOV, A., ELSTEIN, D., GROSS-TSUR, V., FARBER, B., GLASER, Y., HADAS-HALPERN, I., RONEN, S., TAFAKJDI, M., HOROWITZ, M., and ZIMRAN, A. (1995). Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet 346, 1000-1003.
2. AGMON, V., CHERBU, S., DEGAN, A., GRACE, M.E., GRABOWSKI, G.A., and GATT, S. (1993). Synthesis of novel fluorescent glycosphingolipids: Use in determining acid beta-glucosidase activity in situ and correlation with genotype in Gaucher disease. Biochim. Biophys. Acta. 1170, 72-79.
3. BERREBI, A., WISHNITZER, R., and VON-DER-WALDE, U. (1984). Gaucher's disease: Unexpected diagnosis in three patients over seventy years old. Nouv. Rev. Fr. Hematol. 26, 201-203.
4. BEUTLER, E. (1977). Gaucher's disease in an asymptomatic 72-year-old. JAMA 237, 2529.
5. BEUTLER, E., GELBART, T., KUHL, W., ZIMRAN, A., and WEST, C. (1992). Mutations in Jewish patients with Gaucher disease. Blood 79, 1662-1666.
6. BEUTLER, E., NGUYEN, N.J., HENNEBERGER, M.W., SMOLEC, J.M., MCPHERSON, R.A., WEST, C., and GELBART, T. (1993). Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am. J. Hum. Genet. 52, 85-88.
7. BEUTLER, E., and GELBART, T. (1997). Hematologically important mutations: Gaucher disease. Blood Cells, Molecules and Diseases 23, 2-7.
8. BEUTLER, E., and GRABOWSKI, G.A. (1995). Glucosylceramide lip-idoses: Gaucher disease. In The Metabolic and Molecular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds. p. 2641. McGraw-Hill, New York.
9. BORNSTEIN, P., LAMARCA, M.E., MCKINNEY, C.E., WINFIELD, S., SHINGU, T., VOS, H.L., and GINNS, E.I. (1994). Targeted disruption of a novel gene contiguous to both glucocerebrosidase (GC) and thrombospondin (TSP3) results in an embryonic lethal phenotype in the mouse. Am. J. Hum. Genet. 55, A129.
10. CONZELMANN, E., and SANDHOFF, K. (1983). Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev. Neurosci. 6, 58-71.
11. CORMAND, B., VILAGELIU, L., BURGUERA, J.M., BALCELLS, S., GONZALEZ-DUARTE, R., GRINBERG, D., and CHABAS, A. (1995). Gaucher disease in Spanish patients: analysis of eight mutations. Hum. Mutat. 5, 303-309.
12. DAHL, N., LAGERSTRÖM, M., ERIKSON, A., and PETTERSSON, U. (1990). Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am. J. Hum. Genet. 47, 275-278.
13. DREBORG, S., ERIKSON, A., and HAGBERG, B. (1980). Gaucher disease - Norrbottnian type. I. General clinical description. Eur. J. Pediatr. 133, 107-118.
14. ERIKSON, A. (1986). Gaucher disease - Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr. Scand. Suppl. 326, 1-42.
15. ETO, Y., KAWAME, H., HASEGAWA, Y., OHASHI, T., IDA, H., and TOKORO, T. (1993). Molecular characteristics in Japanese patients with lipidosis: novel mutations in metachromatic leukodystrophy and Gaucher disease. Mol. Cell Biochem. 119, 179-184.
16. FREDERICKSON, D.S., and SLOAN, H.R. (1978). Glucosyl ceramide lipidoses: Gaucher's disease. In The Metabolic Basis of Inherited Disease J.B. Stanbury, J.B. Wyngaarden, and D.S. Frederickson, eds., p. 730. McGraw-Hill, New York.
17. GRABOWSKI, G.A., GATT, S., and HOROWITZ, M. (1990). Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit. Rev. Biochem. Mol. Biol. 25, 385-414.
18. GRABOWSKI, G.A., SAAL, H., WENSTRUP, R.J., and BARTON, N.W. (1996). Gaucher disease: A prototype for molecular medicine. Crit. Rev. Hemat. Oncol. 23, 25-55.
19. GRACE, M.E., GRAVES, P.N., SMITH, F.I., and GRABOWSKI, G.A. (1990). Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations. J. Biol. Chem. 265, 6827-6835.
20. GRACE, M.E., BERG, A., HE, G.S., GOLDBERG, L., HOROWITZ, M., and GRABOWSKI, G.A. (1991). Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes. Am. J. Hum. Genet. 49, 646-655.
21. GRACE, M.E., NEWMAN, K.M., SCHEINKER, V., HE, G., BERGFUSSMAN, A., and GRABOWSKI, G.A. (1994). Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. J. Biol. Chem. 269, 2283-2291.
22. HE, G., and GRABOWSKI, G.A. (1992). Gaucher disease: A G(+1) to A(+1) IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA. Am. J. Hum. Genet. 51, 810-820.
23. HOROWITZ, M., WILDER, S., HOROWITZ, Z., REINER, O., GELBART, T., and BEUTLER, E. (1989). The human glucocerebrosidase gene and pseudogene: Structure and evolution. Genomics 4, 87-96.
24. HOROWITZ, M., TZURI, G., EYAL, N., BEREBI, A., KOLODNY, E.H., BRADY, R.O., BARTON, N.W., ABRAHAMOV, A., and ZIMRAN, A. (1993). Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am. J. Hum. Genet. 53, 921-930.
25. HOROWITZ, M., and ZIMRAN, A. (1994). Mutations causing Gaucher disease. Human Mutation 3, 1-11.
26. KAWAME, H., and ETO, Y. (1991). A new glucocerebrosidase-gene missense mutation responsible for neuronopathic Gaucher disease in Japanese patients. Am. J. Hum. Genet. 49, 1378-1380.
27. KIM, J., PONCE, E., LAI, M., LIOU, B., and GRABOWSKI, G.A. (1996). Gaucher disease: Identification of three new mutations in the Korean and Chinese (Taiwanese) population. Human Mutation 7, 214-218.
28. KOLODNY, E.H., ULLMAN, M.D., MANKIN, H.J., RAGHAVAN, S.S., TOPOL, J., and SULLIVAN, J.L. (1982). Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. Prog. Clin. Biol. Res. 95, 33-65.
29. LATHAM, T., GRABOWSKI, G.A., THEOPHILUS, B.D., and SMITH, F.I. (1990). Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am. J. Hum. Genet. 47, 79-86.
30. LEWIS, B.D., NELSON, P.V., ROBERTSON, E.F., and MORRIS, P.C. (1994). Mutation analysis of 28 Gaucher disease patients: The australasian experience. Am. J. Med. Genet. 49, 218-223.
31. MEDOFF, A.S., and BAYRD, E.D. (1954). Gaucher's disease in 29 cases: Hematologic complications and effect of splenectomy. Isr. J. Med. Sci. 40, 481-492.
32. MORAR, B., & LANE, A.B. (1996). The molecular characterization of Gaucher disease in South Africa. Clin. Genet. 50, 78-84.
33. OHASHI, T., HONG, C.M., WEILER, S., TOMICH, J.M., AERTS, J.M.F.G., TAGER, J.M., and BARRANGER, J.A. (1991). Characterization of human glucocerebrosidase from different mutant alleles. J. Biol. Chem. 266, 3661-3669.
34. PATTERSON, M.C., HOROWITZ, M., ABEL, R.B., CURRIE, J.N., BRADY, R.O., and BARTON, N.W. (1993). Isolated horizontal supranuclear gaze palsy as a marker for severe systemic involvement in Gaucher's disease. Neurology 43, 1993-1997.
35. PONCE, E., and GRABOWSKI, G.A. (1997). Human acid β-glucosidase: Contextual dependence of Gaucher disease mutations: Recovery of enzyme function by pseudoreversion. unpublished.
36. SIBILLE, A., ENG, C.M., KIM, S.J., PASTURES, G., and GRABOWSKI, G.A. (1993). Phentoype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am. J. Hum. Genet. 52, 1094-1101.
37. SIDRANSKY, E., SHERER, D.M., and GINNS, E.I. (1992). Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr. Res. 32, 494-498.
38. TAYEBI, N., NERMAN, J., GINNS, E.I., and SIDRANSKY, E. (1996). Genotype D399N/R463C in a patient with type 3 Gaucher disease previously assigned genotype N370S/R463C. Biochem. Mol. Med. 57, 149-151.
39. THEOPHILUS, B., LATHAM, T., GRABOWSKI, G.A., and SMITH, F.I. (1989a). Gaucher disease: molecular heterogeneity and phenotype-genotype correlations. Am. J. Hum. Genet. 45, 212-225.
40. THEOPHILUS, B.D., LATHAM, T., GRABOWSKI, G.A., and SMITH, F.I. (1989b). Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid β-glucosidase gene. Nucleic Acid Res. 17, 7707-7722.
41. ZIMRAN, A., GELBART, T., WESTWOOD, B., GRABOWSKI, G.A., and BEUTLER, E. (1991). High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am. J. Hum. Genet. 49, 855-859.
42. ZIMRAN, A., KAY, A., GELBART, T., GARVER, P., THURSTON, D., SAVEN, A., and BEUTLER, E. (1992). Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine 71, 337-353.